Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Aurinia Pharmaceuticals Inc Stock Price (Quote) NASDAQ:AUPH
$11.93 ( 4.19% ) Friday, 27th May 2022
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $8.86 | $12.39 | Friday, 27th May 2022 AUPH stock ended at $11.93. This is 4.19% more than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 5.51% from a day low at $11.34 to a day high of $11.97. |
| 90 days | $8.86 | $13.11 | |
| 52 weeks | $8.86 | $33.97 |
Historical Aurinia Pharmaceuticals Inc prices
| Date | Open | High | Low | Close | Volume |
| 2022-05-27 | $11.53 | $11.97 | $11.34 | $11.93 | 1 228 556 |
| 2022-05-26 | $11.34 | $11.79 | $11.30 | $11.45 | 924 997 |
| 2022-05-25 | $11.29 | $11.57 | $11.07 | $11.36 | 751 502 |
| 2022-05-24 | $11.57 | $11.60 | $11.15 | $11.31 | 1 177 017 |
| 2022-05-23 | $12.04 | $12.39 | $11.74 | $11.84 | 1 999 269 |
| 2022-05-20 | $11.75 | $12.12 | $11.15 | $12.05 | 2 304 881 |
| 2022-05-19 | $11.07 | $11.78 | $11.07 | $11.65 | 1 803 280 |
| 2022-05-18 | $11.21 | $11.48 | $11.03 | $11.21 | 1 658 150 |
| 2022-05-17 | $11.19 | $11.63 | $10.93 | $11.45 | 2 020 476 |
| 2022-05-16 | $11.15 | $11.77 | $10.90 | $10.99 | 2 134 548 |
| 2022-05-13 | $10.13 | $11.38 | $10.08 | $11.17 | 3 428 996 |
| 2022-05-12 | $9.39 | $9.89 | $9.11 | $9.89 | 3 105 330 |
| 2022-05-11 | $11.02 | $11.23 | $9.45 | $9.58 | 3 893 350 |
| 2022-05-10 | $9.61 | $11.34 | $9.61 | $11.27 | 5 761 500 |
| 2022-05-09 | $9.86 | $10.06 | $8.86 | $8.95 | 4 627 845 |
| 2022-05-06 | $10.86 | $10.86 | $10.09 | $10.16 | 2 525 832 |
| 2022-05-05 | $11.29 | $11.38 | $10.67 | $10.85 | 2 268 332 |
| 2022-05-04 | $11.12 | $11.37 | $10.55 | $11.37 | 3 582 664 |
| 2022-05-03 | $10.86 | $11.15 | $10.77 | $11.12 | 1 519 680 |
| 2022-05-02 | $10.30 | $10.91 | $10.18 | $10.89 | 1 437 238 |
| 2022-04-29 | $10.49 | $10.82 | $10.26 | $10.29 | 1 159 360 |
| 2022-04-28 | $10.78 | $10.95 | $9.70 | $10.52 | 2 757 707 |
| 2022-04-27 | $10.99 | $11.25 | $10.76 | $10.80 | 1 077 354 |
| 2022-04-26 | $11.26 | $11.39 | $10.92 | $10.93 | 1 586 244 |
| 2022-04-25 | $10.67 | $11.60 | $10.65 | $11.39 | 1 590 733 |
| 2022-04-22 | $10.89 | $11.46 | $10.78 | $10.83 | 551 791 |
| 2022-04-21 | $11.66 | $11.87 | $10.88 | $10.95 | 1 742 300 |
| 2022-04-20 | $11.16 | $11.74 | $10.72 | $11.53 | 1 746 600 |
| 2022-04-19 | $11.31 | $11.36 | $11.02 | $11.15 | 1 653 500 |
| 2022-04-18 | $11.79 | $11.79 | $11.24 | $11.30 | 1 547 000 |
| 2022-04-14 | $12.28 | $12.28 | $11.69 | $11.85 | 1 060 434 |
| 2022-04-13 | $11.62 | $12.34 | $11.56 | $12.28 | 1 222 024 |
| 2022-04-12 | $11.99 | $12.16 | $11.50 | $11.61 | 1 446 876 |
| 2022-04-11 | $11.77 | $12.10 | $11.46 | $11.91 | 1 523 175 |
| 2022-04-08 | $12.01 | $12.30 | $11.78 | $11.95 | 1 045 148 |
| 2022-04-07 | $12.02 | $12.32 | $11.71 | $12.12 | 1 046 500 |
| 2022-04-06 | $11.96 | $12.16 | $11.52 | $12.07 | 1 393 300 |
| 2022-04-05 | $12.60 | $12.75 | $12.06 | $12.11 | 1 089 500 |
| 2022-04-04 | $12.61 | $12.89 | $12.42 | $12.55 | 1 627 800 |
| 2022-04-01 | $12.42 | $13.11 | $12.38 | $12.59 | 2 690 705 |
| 2022-03-31 | $12.37 | $12.65 | $12.33 | $12.37 | 1 528 433 |
| 2022-03-30 | $12.58 | $12.84 | $12.33 | $12.38 | 1 334 202 |
| 2022-03-29 | $12.47 | $12.77 | $12.29 | $12.69 | 1 059 259 |
| 2022-03-28 | $12.49 | $12.73 | $11.96 | $12.35 | 932 000 |
| 2022-03-25 | $12.49 | $12.68 | $12.22 | $12.45 | 1 506 300 |
| 2022-03-24 | $12.60 | $12.99 | $12.39 | $12.80 | 1 572 500 |
| 2022-03-23 | $12.42 | $13.00 | $12.29 | $12.51 | 1 222 800 |
| 2022-03-22 | $11.72 | $12.87 | $11.65 | $12.50 | 2 856 148 |
| 2022-03-21 | $11.95 | $12.29 | $11.52 | $11.78 | 2 288 272 |
| 2022-03-18 | $11.62 | $12.25 | $11.58 | $11.95 | 2 603 980 |
Aurinia Pharmaceuticals Inc., a clinical stage pharmaceutical company, engages in the development of a therapeutic drug to treat autoimmune diseases in Canada. The companys lead drug candidate is Voclosporin, a calcineurin inhibitor, which is in Phase IIb clinical trial for the treatment of lupus nephritis. It has a collaboration agreement with Paladin Labs Inc. to maintain the patent portfolio for Voclosporin in Canada, South Africa, and Israe... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
